C1QTNF3

Across TCGA pan-cancer cohorts, C1QTNF3 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of C1QTNF3’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where C1QTNF3 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types C1QTNF3 is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.

PDAC, HNSC, and CCRCC are the cancer types where C1QTNF3 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in C1QTNF3 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PDAC	Female	II,III,IV	+1.270	<.001	6	view →
HNSC	Male	All	−0.636	<.001	6	view →
CCRCC	All	All	+0.484	<.001	6	view →
LSCC	All	All	+0.607	<.001	5	view →
LUAD	Male	All	+0.580	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

C1QTNF3–PDAC

Open the PDAC breakdown →